| PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8+ T cells K Karwacz, C Bricogne, D MacDonald, F Arce, CL Bennett, M Collins, ... EMBO molecular medicine 3 (10), 581-592, 2011 | 333 | 2011 |
| PD-L1/PD-1 co-stimulation, a brake for T cell activation and a T cell differentiation signal T Liechtenstein, I Dufait, C Bricogne, A Lanna, J Pen, K Breckpot, ... Journal of clinical & cellular immunology, 2012 | 63 | 2012 |
| TMEM16F activation by Ca2+ triggers plasma membrane expansion and directs PD-1 trafficking C Bricogne, M Fine, PM Pereira, J Sung, M Tijani, Y Wang, R Henriques, ... Scientific reports 9 (1), 619, 2019 | 55 | 2019 |
| PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy K Karwacz, F Arce, C Bricogne, G Kochan, D Escors Oncoimmunology 1 (1), 86-88, 2012 | 55 | 2012 |
| Retroviral and lentiviral vectors for the induction of immunological tolerance I Dufait, T Liechtenstein, A Lanna, C Bricogne, R Laranga, A Padella, ... Scientifica 2012, 2012 | 51 | 2012 |
| Immune modulation by genetic modification of dendritic cells with lentiviral vectors T Liechtenstein, N Perez-Janices, C Bricogne, A Lanna, I Dufait, ... Virus research 176 (1-2), 1-15, 2013 | 28 | 2013 |
| On the Mechanism of T cell receptor down-modulation and its physiological significance D Escors, C Bricogne, F Arce, G Kochan, K Karwacz The journal of bioscience and medicine 1 (1), 2011 | 28 | 2011 |
| Targeted lentiviral vectors: current applications and future potential C Goyvaerts, T Liechtenstein, C Bricogne, D Escors, K Breckpot Gene Therapy-Tools and Potential Applications, 2013 | 21 | 2013 |
| Lentiviral vectors in immunotherapy I Dufait, T Liechtenstein, A Lanna, R Laranga, A Padella, C Bricogne, ... Gene Therapy-Tools and Potential Applications, 2013 | 9 | 2013 |
| Donor–recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplant C Bricogne, N Halliday, R Fernando, EA Tsochatzis, BR Davidson, ... Liver Transplantation, 2022 | 6 | 2022 |
| Critical mass hypothesis of T-cell responses and its application for the treatment of T-cell lymphoma C Bricogne, R Laranga, A Padella, I Dufait, T Liechtenstein, K Breckpot, ... Hodgkin’s and T-cell lymphoma: Diagnosis, Treatment Options and Prognosis …, 2012 | 5 | 2012 |
| Massive surface membrane expansion without involvement of classical exocytic mechanisms M Fine, C Bricogne, DW Hilgemann BioRxiv, 249284, 2018 | 3 | 2018 |
| HLA-A mismatching is associated with an increased risk of hepatic artery thrombosis, sepsis, graft loss and reduced survival following liver transplant C Bricogne, N Halliday, R Fernando, E Tsochatzis, M Harber, ... JOURNAL OF HEPATOLOGY 75, S236-S236, 2021 | | 2021 |
| Positive complement-dependent cytotoxicity crossmatch results do not influence long-term graft or patient survival following liver transplantation C Bricogne, N Halliday, R Fernando, L De Luca, M Rodríguez-Perálvarez, ... Journal of Hepatology 73, S272, 2020 | | 2020 |
| Plasma Membrane Dynamics Regulating the PD-1/PD-L1 Pathway CC Bricogne UCL (University College London), 2015 | | 2015 |
| Interference with PD-L1/PD-1 co-stimulation results in effective anti-tumour immunity by preventing ligand-induced T cell receptor D Escors, T Liechtenstein, N Perez-Janices, A Lanna, C Bricogne, ... Human Gene Therapy 24 (12), 170-170, 2013 | | 2013 |
| Massive surface membrane expansion without involvement M Fine, C Bricogne, DW Hilgemann | | |
